A clinical study to test the effectiveness of homoeopathic remedies of Cimcifuga Racemosa and Rhododendron Chrysanthum in treating trapezitis.

A Comparative Study To Assess The Efficacy Of Cimcifuga Racemosa 1 M And Rhododendron Chrysanthum 1 M In Cases Of Trapezitis - A Clinical Study In The Age Group Of 20-50 Years - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076855

Enrollment

Registered

2024-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: Cimcifuga Racemosa: Cimcifuga Racemosa - Potentised Homoeopathic medicine Cimcifuga Racemosa given in the form of pills. Dose : 1 Dose followed by four pills BD.Potency:1M. Route of adm

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 20-50 years. 2. Both Sexes. 3. Patient who willing to give consent. 4. Those cases fulfilling case definition.

Exclusion criteria

Exclusion criteria: 1. Age less than 20 and more than 50. 2. Pregnant and Lactating mothers. 3.Past medical history of any other musculoskeletal diseases, malignancy and HIV cases are excluded.

Design outcomes

Primary

Measure	Time frame
To assess the improvement of symptoms of trapezitis by using Cimcifuga Racemosa 1M and Rhodendron Chrysanthum 1M.Timepoint: 3 months with followup in each 15 days.	—

Secondary

Measure	Time frame
To assess the intensity of symptoms by Visual Analogue Scale.Timepoint: 3 months with followup in each 15 days.	—

Countries

India

Contacts

Public ContactDr Sumi TS

Bharati Vidyapeeth Deemed To Be University Homoeopathic Medical College And Hospital

neha.jadhavrao@gmail.com9923003441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026